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ABSTRACT
Introduction: In critically ill patients, acute respiratory
distress syndrome (ARDS) and ventilator-associated
conditions (VACs) are associated with increased
mortality, survivor morbidity and healthcare resource
utilisation. Studies conclusively demonstrate that initial
ventilator settings in patients with ARDS, and at risk
for it, impact outcome. No studies have been
conducted in the emergency department (ED) to
determine if lung-protective ventilation in patients at
risk for ARDS can reduce its incidence. Since the ED is
the entry point to the intensive care unit for hundreds
of thousands of mechanically ventilated patients
annually in the USA, this represents a knowledge gap
in this arena. A lung-protective ventilation strategy was
instituted in our ED in 2014. It aims to address the
parameters in need of quality improvement, as
demonstrated by our previous research: (1) prevention
of volutrauma; (2) appropriate positive end-expiratory
pressure setting; (3) prevention of hyperoxia; and (4)
aspiration precautions.
Methods and analysis: The lung-protective
ventilation initiated in the emergency department
(LOV-ED) trial is a single-centre, quasi-experimental
before-after study testing the hypothesis that lung-
protective ventilation, initiated in the ED, is associated
with reduced pulmonary complications. An
intervention cohort of 513 mechanically ventilated
adult ED patients will be compared with over 1000
preintervention control patients. The primary outcome
is a composite outcome of pulmonary complications
after admission (ARDS and VACs). Multivariable
logistic regression with propensity score adjustment
will test the hypothesis that ED lung-protective
ventilation decreases the incidence of pulmonary
complications.
Ethics and dissemination: Approval of the study
was obtained prior to data collection on the first
patient. As the study is a before-after observational
study, examining the effect of treatment changes over
time, it is being conducted with waiver of informed
consent. This work will be disseminated by publication
of full-length manuscripts, presentation in abstract
form at major scientific meetings and data sharing with
other investigators through academically established
means.
Trial registration number: NCT02543554.
INTRODUCTION
In mechanically ventilated patients, pulmon-
ary complications that occur during the
course of critical illness are seminal events
that can signiﬁcantly alter the trajectory of
patient outcome.1 2 Acute respiratory distress
syndrome (ARDS) and ventilator-associated
conditions (VACs) are two categories of these
complications that can occur, and are asso-
ciated with an increase in mortality, survivor
morbidity and healthcare resource
utilisation.1 3
There are no treatment options that
address the underlying pathophysiology of
Strengths and limitations of this study
▪ This is the first trial to specifically implement
lung-protective ventilation in the emergency
department, and to assess the intervention effect
on outcome.
▪ The pragmatic design will allow the enrolment of
a large sample of diverse patients, increasing the
external validity of findings.
▪ The intervention is simple.
▪ A before-after design can make proving caus-
ation difficult and can be affected by temporal
changes in care.
▪ There is no mechanistic outcome, which limits
the ability to assess why exactly the intervention
may be effective.
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ARDS. However, increasing data suggest that certain
modiﬁable variables, if addressed early, can prevent pro-
gression to ARDS. With a mortality rate of approximately
40%, primary prevention is likely the most effective strat-
egy to improve outcome. Similar measures can prevent
VACs, and the Centers for Disease Control and
Prevention/National Healthcare Safety Network (CDC/
NHSN) view VACs as a quality measure for the manage-
ment of mechanically ventilated patients. The emer-
gency department (ED) is the entry point for hundreds
of thousands of mechanically ventilated patients annu-
ally in the USA4. Many of these patients are at high risk
for pulmonary complications, yet the ED remains a rela-
tively unstudied location with respect to the prevention
or mitigation of their occurrence. As ventilator-
associated lung injury (VALI) has been shown to occur
during the ﬁrst few hours of mechanical ventilation, a
preventive intervention in the ED, targeting these high-
risk patients, could be the systematic programme
needed to improve outcome.5 6
Cyclic alveolar overdistention from positive pressure
ventilation is a key element in the pathogenesis of lung
injury. VALI promotes inﬂammatory injury and can
cause pulmonary complications in healthy lungs.
Lung-protective ventilation, by limiting VALI, reduces
mortality in critically ill mechanically ventilated
patients.7 There is also a signiﬁcant amount of data to
suggest that initial ventilator settings are in the causal
pathway for pulmonary complications after initiation of
mechanical ventilation. Observational data, two system-
atic reviews and two randomised trials show that non
lung-protective ventilation, delivered early in the course
of respiratory failure, is associated with an increased
incidence of pulmonary complications in previously
non-injured lungs.2 8–16 Our preliminary data show that
the early use of potentially injurious ventilation is
common in ED patients.17 18 Furthermore, our data
have shown that higher tidal volume delivered in the
ED is associated with an increased incidence in pul-
monary complications.19 Early initiation of lung-
protective ventilation in the ED may therefore be an
effective strategy to reduce complications in this vulner-
able cohort. This has not been a target of previous
research.
Owing to the abundance of data showing a strong
association between initial ventilator settings and clinical
outcomes, as well as the high safety and favourable risk-
beneﬁt proﬁle, a default lung-protective ventilator strat-
egy became the standard approach in our ED in
2014.20–22 To increase our understanding of the role of
ED-based mechanical ventilation on the incidence of
pulmonary complications, we designed the lung-
protective ventilation initiated in the emergency depart-
ment (LOV-ED) trial, a quasi-experimental, before-after
study, with the objective of testing the efﬁcacy of
ED-based lung-protective ventilation in the prevention of




This is a single-centre, quasi-experimental, before-after
study, and is reported in compliance with the Standard
Protocol Items: Recommendations for Intervention
Trials (SPIRIT) statement (see online supplementary
ﬁle). A schematic of the before-after trial design appears
in ﬁgure 1. The hypothesis to be tested is that lung-
protective ventilation, initiated in the ED, is associated
with a reduced rate of pulmonary complications (ARDS
and VACs).
Study population
The preintervention group consists of mechanically ven-
tilated ED patients from September 2009 to 2014; the
postintervention group includes patients managed after
the implementation of an ED-based mechanical ventila-
tor protocol (October 2014). To improve protocol
adherence, a run-in period of approximately 6 months
was performed prior to study initiation. Inclusion cri-
teria are: (1) adult patients aged ≥18 years; and (2)
mechanical ventilation via an endotracheal tube.
Exclusion criteria are: (1) death within 24 h of presenta-
tion; (2) discontinuation of mechanical ventilation
within 24 h of presentation; (3) chronic mechanical ven-
tilation; (4) presence of a tracheostomy; (5) transfer to
another hospital from the ED and (6) fulﬁlment of
ARDS criteria at hospital presentation.
Patients will be recruited exclusively from the ED at
Barnes-Jewish Hospital/Washington University School of
Medicine in St Louis. Based on the demographics of the
patient population routinely presenting to our hospital,
the resulting study population is expected to be approxi-
mately 55% male, 50% white, 45% African-American and
5% other races. We expect a similar distribution, but will
enrol patients without regard to gender or race. We there-
fore expect that the study ﬁndings will hold external val-
idity and be applicable to the community as a whole.
For the preintervention arm of the study, the Clinical
Investigation Data Exploration Repository (CIDER) will
be used to identify patients receiving mechanical ventila-
tion in the ED. CIDER was developed to maintain elec-
tronic health records at Washington University and
Figure 1 Schematic of before-after trial design.
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Barnes-Jewish Hospital sites, including both inpatient
and outpatient encounters. To maximise the retrieval of
all mechanically ventilated patients in the ED from our
prespeciﬁed timeframe, we investigated three methods,
utilising: (1) International Classiﬁcation of Diseases
(ICD)-9 codes, (2) current procedural terminology
(CPT) codes and (3) a Boolean keyword search of ED
documents. Results from a previously published pro-
spective study were used as a test data set in order to val-
idate this methodology and accurately retrieve the study
cohort of all patients who were mechanically ventilated
while in the ED.18 The Boolean keyword search method
was observed to be the superior method over ICD-9 and
CPT codes, and yielded retrieval with perfect precision
(1.0). Therefore, for the current study, patients will be
identiﬁed by querying CIDER using keyword extraction
from ED documents. The ﬁnal keyword search to iden-
tify the full cohort will be:+(‘intubation’ OR ‘intubated’)
AND—(‘rapid sequence intubation induction’ AND
‘intubated patients’) AND+(‘ETT’ OR ‘ventilator set-
tings’ OR ‘endotracheal tube’ OR ‘ET’) AND
+(‘ETCO2’ OR ‘color change’ OR ‘ventilator’ OR ‘venti-
lator order’ OR ‘vent management’ OR ‘ET placement’
OR ‘capnography’ OR ‘sedation’ OR ‘resuscitation’).
For the prospective, postintervention arm of the study,
screening for enrolment will be facilitated using an auto-
mated, electronic pager system (Computer-Assisted
Subject Enrollment for the Emergency Department;
CASE-ED). This system screens patients 24 h a day,
7 days a week. For the purposes of the current study, it
will be programmed to trigger an alert for any one of
the following: (1) an order for ventilator settings in the
ED; (2) an order for neuromuscular blockers (eg, suc-
cinylcholine, rocuronium) or (3) documentation of
endotracheal intubation. Furthermore, the bedside
respiratory therapist will send a notiﬁcation via email to
the study principal investigator (PI) whenever mechan-
ical ventilation is initiated on any patient. This approach
has been used before and allows the capture of every
patient receiving mechanical ventilation while in the
ED.18
Interventions
A default lung-protective ventilation strategy was insti-
tuted in 2014 in our ED. It aims to improve adherence
with principles of high-quality mechanical ventilation
practice, and address the parameters in need of quality
improvement, as demonstrated by our previous research:
(1) prevention of volutrauma, (2) appropriate positive
end-expiratory pressure (PEEP) setting, (3) limitation of
hyperoxia and (4) aspiration precautions. The ED venti-
lator protocol is shown in ﬁgure 2. Brieﬂy, after endo-
tracheal intubation is accomplished and conﬁrmed, the
ED respiratory therapist will obtain an accurate height
with a tape measure. Ventilator settings are then estab-
lished according to the protocol in ﬁgure 2, and
head-of-bed elevation is performed in all patients, unless
speciﬁcally contraindicated by clinical care protocols (ie,
head of bead elevation may be contraindicated in
patients with suspected cervical spine fracture).
We take a pragmatic approach to the study design,
and therefore co-interventions (eg, antibiotics and ﬂuid
management) that may inﬂuence the event rate for the
primary outcome will not be standardised, and will be at
the discretion of the treating clinician. While this intro-
duces a potential risk of an imbalanced cohort for com-
parison, and therefore potential to limit the ability to
detect an effect of the intervention, we have chosen this
approach: (1) to maximise generalisability to the com-
munity as a whole; (2) because no systematic differences
in care (excluding lung-protective ventilation) that may
inﬂuence the event rate of interest have been intro-
duced in the ED at Barnes-Jewish Hospital; (3) because
an overwhelming majority of mechanically ventilated
patients have been excluded in randomised trials, con-
tributing to the poor implementation of critical care
research ﬁndings in this cohort;23 and (4) because our
ED has several processes of care that are already standar-
dised via well-established protocols (ie, quantitative
resuscitation for sepsis, transfusion), and/or order sets
(ie, rapid sequence intubation, antibiotics, etc), which
provides relative assurance for additional standardisation
of care with respect to co-interventions. We will statistic-
ally analyse any potential differences in baseline
characteristics, illness severity and process-of-care vari-
ables between the before and after groups.
Additional variables of interest include baseline demo-
graphics, comorbid conditions, vital signs at presenta-
tion, laboratory variables (including arterial blood gas
and baseline oxygenation), illness severity scores (ie,
Acute Physiology and Chronic Health Evaluation
(APACHE II), Sequential Organ Failure Assessment
(SOFA)), location of intubation, ED length of stay and
indication for initiation of mechanical ventilation.
Treatment variables in the ED include intravenous ﬂuid,
receipt of blood products, central venous catheter and
arterial catheter placement, antibiotics, and vasopressor
use. Pertinent clinical data after admission will also be
included. Table 1 and ﬁgure 3 show a full description of
events for this study.
Outcomes
The primary outcome of interest is a composite
outcome of pulmonary complications after admission:
ARDS and VACs. ARDS will be deﬁned according to the
Berlin deﬁnition, and will be analysed through day 7, as
data suggest that the majority of ARDS cases will develop
within this time period.17 18 24 25 Adjudication of ARDS
status will occur in a systematic fashion, per the previ-
ously published standard operating procedure of our
research team.18 Each investigator will review a set of
training radiographs in order to reduce heterogeneity in
X-ray interpretation, and will be blinded to ventilator set-
tings.26 For patients with an equivocal ARDS adjudica-
tion status after primary review, an independent
(blinded) expert investigator will further review the
Fuller BM, et al. BMJ Open 2016;6:e010991. doi:10.1136/bmjopen-2015-010991 3
Open Access
group.bmj.com on April 16, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
X-rays. Patients fulﬁlling ARDS oxygenation criteria
within a 24 h window of having bilateral inﬁltrates not
fully explained by myocardial dysfunction or ﬂuid over-
load, will be deemed to have ARDS. VACs will be deﬁned
according to the CDC deﬁnition.1 Per these criteria, a
patient must be mechanically ventilated for ≥4 days to
qualify for a VAC. This includes 2 days of stable or improv-
ing ventilator settings, followed by 2 days of worsening
oxygenation, represented by an increase in fraction of
inspired oxygen of ≥0.20 (20%) or PEEP ≥3 cm H2-
O. Therefore, the denominator for VACs will be those
patients ventilated ≥4 days. For the purposes of this study,
the minimum PEEP level to deﬁne a VAC will be
2.5 cm H2O, as our experience shows that most PEEP
changes at our centre occur in increments of 2.5 cm H2-
O. VACs will be analysed until day 14, as data suggest that
the majority of VACs develop within this time period.1
Secondary outcomes include hospital and intensive
care unit (ICU) lengths of stay, ventilator and vasopres-
sor duration, and mortality.
Proposed statistical methods
There are two cohorts of interest: (1) a preintervention
group, prior to the implementation of a lung-protective
Figure 2 ED protocol for mechanical ventilation in the immediate postintubation period. ARDS, acute respiratory distress
syndrome; ED, emergency department; PBW, predicted body weight; PEEP, positive end-expiratory pressure; BMI, body mass
index; FiO2, fraction of inspired oxygen; SpO2, peripheral oxygen saturation; PaO2, partial pressure of arterial oxygen; iPEEP,
intrinsic PEEP.
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Illness severity scores X
Vitals and laboratory data X
ED treatment variables X
ED ventilator data X
ICU ventilator data (twice daily) X X X X X X X X
SOFA score X X
RASS score X X
CAM-ICU X X
Fluid balance X X X X X X X X
Transfusion X X X X X X X X
ARDS outcome X X X X X X X
VAC outcome X X X X X X
Mortality X
Other secondary outcomes X
ARDS, acute respiratory distress syndrome; CAM, confusion assessment method; ED, emergency department; ICU, intensive care unit; LPV, lung-protective ventilation; RASS, Richmond



























ventilator protocol; and (2) a postintervention group
managed with a ventilator protocol as described above,
and in ﬁgure 2. Categorical characteristics will be com-
pared using the χ2 test or Fisher’s exact test. Continuous
characteristics will be compared using the independent
samples t test or Wilcoxon’s rank-sum test. The primary
analysis will compare the proportion of patients in each
cohort with and without the occurrence of pulmonary
complications (eg, ARDS or VACs) using logistic regres-
sion with propensity score (PS) adjustment.
Multivariable logistic regression will be used to derive
the PS, with cohort as the dependent variable. Cohort 2
patients will be categorizsd into quintile subclasses based
on their ranked estimated PS and then matched to
cohort 1 patients to achieve a similar distribution of cov-
ariates. Unmatched cases in cohort 1 will be discarded.
Simple diagnostics and linear regression testing for a
quintile by cohort interaction will be used to verify
balance, and if not achieved, PSs will be re-estimated
using transformations or interactions. In ﬁnal logistic
regression, the treatment effect is deﬁned as the odds of
pulmonary complication as a function of cohort, with
adjustment for the quintiles of the PS. Development of
ARDS and VACs will also be analysed separately.
Secondary outcome variables will be compared using
PS-adjusted logistic regression (mortality) and
PS-adjusted Poisson regression (lengths of ICU/hospital
stay, mechanical ventilation days). We will conduct a
priori subgroup analyses to further understand the treat-
ment effect and identify subgroups in which heteroge-
neous treatment effects exist. These subgroups include
(but are not limited to) sepsis, trauma, neurological
injury and presence of shock. Missing data will be
handled by multiple imputation methods. On study
completion, other statistical methods will be explored as
necessary, and all analyses will be conducted in consult-
ation with a biostatistician.
The sample size is calculated for the primary
outcome, the development of pulmonary complications.
We expect an event rate of approximately 20% in the
before group.1 10 18 As a reﬂection of a decrease in
VALI, we expect an absolute risk reduction of 5.4% for
pulmonary complications in the after group. This will
require a total sample size of postintervention
participants of 513 to have 80% power. All tests will be
two-tailed, and a p value <0.05 will be considered statis-
tically signiﬁcant.
Data storage and management
All data will be entered by one research assistant and
data accuracy will be veriﬁed by the study PI. Data
quality control measures will include queries to identify
missing data, outliers and discrepancies. Only the
research assistant and study PI will have access to pro-
tected health information. After enrolment, a unique
identiﬁer (ID) will be assigned to each study participant.
This ID will be linked to the participant’s medical
record number, and this hard copy roster will be stored
in a locked cabinet in the PI’s locked private ofﬁce. All
computers will be password-protected and encrypted per
university policy. The PI will ensure that the anonymity
is maintained. Patients will not be identiﬁed by name in
any reports on this study. The study PI will have access to
the ﬁnal trial data set, as will a consulting biostatistician
(in a de-identiﬁed state).
ETHICS AND DISSEMINATION
Ethics approval
The study protocol received ethical approval by the
Human Research Protection Ofﬁce at Washington
University in St Louis School of Medicine (Institutional
Review Board identiﬁcation number 201409024) prior
to beginning the study. As the study is a before-after
observational study, examining the effect of treatment
changes over time, it was conducted with waiver of
informed consent.
Dissemination and data sharing
Sharing of data generated by this project is an essential
part of the proposed activities and will be shared with
collaborators as soon as available. It will be carried out
in several different ways. Data and resources will be
shared with other eligible investigators through academ-
ically established means. Results will be made available
both to the community of scientists interested in mech-
anical ventilation and ARDS to avoid unintentional
duplication of research. Collaboration with others
Figure 3 Planned operations for intervention study period (after group). ED, emergency department; ICU, intensive care unit;
LOS, length of stay; VAC, ventilator-associated condition; ARDS, acute respiratory distress syndrome.
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investigators interested in establishing lung-protective
ventilation protocols in the ED will be welcomed. On
completion of all follow-up data, this work will be pub-
lished as full-length manuscripts and presented in
abstract form at national meetings in critical care medi-
cine and emergency medicine.
DISCUSSION
Critical care medicine has historically been practiced
within the walls of the ICU. However, there is increased
recognition of the large number of critically ill and
at-risk patients cared for outside the ICU (eg, ED, hos-
pital ward, operating room). Provision of time-sensitive
therapy prior to ICU arrival can save lives, and providing
‘critical care without walls’ is now recognised as a major
priority to improve outcome.27
This has yet to extend on a large scale to the clinical
practice or study of mechanical ventilation in the ED.
We believe there is opportunity to improve outcome by
targeting this cohort, given that: (1) >200 000 patients
are ventilated in the ED in the USA annually, and these
numbers are increasing4 28 29; (2) lengths of stay in the
ED are sufﬁcient to induce lung injury30; (3) there is a
clear temporal link between pulmonary complications
and admission from the ED17–19 25; (4) initial ventilator
management inﬂuences outcome, both for patients
with, and at risk for, ARDS2 8–16 31; and (5) ventilator set-
tings in the ED are often in the injurious range and
have been linked to ARDS development.17–19
The LOV-ED trial was designed to assess the role of
ED-based mechanical ventilation on the prevention of
pulmonary complications after admission to the ICU.
This is the ﬁrst trial to speciﬁcally implement lung-
protective ventilation in the ED, and to assess the inter-
vention effect on outcome.
Our study has several strengths. In prior randomised
trials of patients with ARDS, 80–90% of screened
patients are excluded.23 This likely contributes to poorly
generalisable results to the community as a whole, and
poor subsequent implementation of lung protection.32
As a pragmatic, quasi-experimental study, the LOV-ED
trial will enrol a large sample of diverse patients, and
the design will allow capture of all eligible patients,
increasing the external validity of ﬁndings. Complex crit-
ical care interventions have also been implemented
poorly in the ED.33 The intervention is also simple and
with little-to-no increased cost. It will also be implemen-
ted from the initiation of mechanical ventilation by non-
physician providers (ie, respiratory therapists), allowing
this strategy to be universally applied per protocol in any
ED if the LOV-ED trial demonstrates beneﬁt. Finally, the
pragmatic design does not mandate the control of
co-interventions, increasing its external validity.
The study also has some limitations. The before-after
study design can make proving causation difﬁcult. Given
the abundance of preclinical and clinical data, including
our data from the ED, a randomised trial would have
ethical implications with respect to equipoise.
Before-after studies are also hindered by temporal
changes and imbalance between groups; these will be
analysed and reported in our results. The effect of the
intervention (and power of the trial) will be reduced if
adherence to the protocol is poor and patients do not
receive it. Adherence will be assured in several ways. The
intervention is relatively simple, easy to apply and well
tolerated, which is associated with greater adherence in
clinical studies. A run-in period will be used prior to the
beginning of the study, in which respiratory therapists
and emergency medicine clinicians will be educated
regarding the importance of adherence and scientiﬁc
merit of the intervention. Finally, we will track adher-
ence in real time and provide feedback and recommen-
dations via electronic mail if there was no identiﬁable
reason for protocol non-adherence. The effect of the
intervention could also be reduced if ICU ventilator set-
tings are vastly different than those received in the ED.
Based on our previous work, we do not expect this to
occur.18 The ventilator protocol is also a bundled
approach to improving outcome. Without a mechanistic
outcome, it will be difﬁcult to tell where an improve-
ment in outcome is exactly being derived from.
However, we ﬁnd this less important than the actual
improvement in outcome.
The LOV-ED trial could be a pivotal study in changing
how mechanical ventilation is used in the ED. We hope
that this is a step forward in the study and care of critic-
ally ill mechanically ventilated patients.
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